| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcal Infections | 16 | 2015 | 37 | 4.020 |
Why?
|
| Streptococcus pyogenes | 16 | 2009 | 29 | 3.380 |
Why?
|
| Pre-Eclampsia | 11 | 2022 | 67 | 3.090 |
Why?
|
| Texas | 32 | 2026 | 457 | 2.390 |
Why?
|
| Anaphylaxis | 7 | 2012 | 15 | 2.210 |
Why?
|
| Length of Stay | 17 | 2016 | 229 | 2.080 |
Why?
|
| Fasciitis, Necrotizing | 9 | 2008 | 11 | 1.860 |
Why?
|
| Retrospective Studies | 34 | 2024 | 2544 | 1.430 |
Why?
|
| Faculty | 3 | 2020 | 105 | 1.430 |
Why?
|
| Hospital Mortality | 11 | 2015 | 210 | 1.300 |
Why?
|
| Eclampsia | 4 | 2011 | 12 | 1.230 |
Why?
|
| Pregnancy | 22 | 2023 | 1772 | 1.220 |
Why?
|
| Humans | 96 | 2026 | 43102 | 1.200 |
Why?
|
| Florida | 20 | 2012 | 478 | 1.140 |
Why?
|
| Hospitalization | 11 | 2021 | 485 | 1.110 |
Why?
|
| Female | 69 | 2026 | 24698 | 1.090 |
Why?
|
| Patient Admission | 5 | 2012 | 50 | 1.060 |
Why?
|
| Mexican Americans | 4 | 2026 | 226 | 0.990 |
Why?
|
| Odds Ratio | 19 | 2018 | 587 | 0.980 |
Why?
|
| Risk Factors | 25 | 2018 | 3994 | 0.970 |
Why?
|
| Regression Analysis | 4 | 2020 | 490 | 0.940 |
Why?
|
| Maternal Age | 4 | 2018 | 33 | 0.930 |
Why?
|
| Adult | 43 | 2026 | 13872 | 0.900 |
Why?
|
| Patient Discharge | 7 | 2023 | 128 | 0.890 |
Why?
|
| Health Care Costs | 2 | 2020 | 91 | 0.850 |
Why?
|
| Streptococcus agalactiae | 2 | 2015 | 8 | 0.830 |
Why?
|
| Colposcopy | 2 | 2021 | 14 | 0.820 |
Why?
|
| Prevalence | 16 | 2024 | 1612 | 0.800 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2021 | 367 | 0.790 |
Why?
|
| Population Surveillance | 6 | 2011 | 246 | 0.750 |
Why?
|
| Adolescent | 22 | 2020 | 6081 | 0.740 |
Why?
|
| Pain | 2 | 2020 | 290 | 0.730 |
Why?
|
| Pregnancy Complications | 4 | 2019 | 140 | 0.720 |
Why?
|
| Seasons | 3 | 2011 | 139 | 0.690 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2021 | 27 | 0.680 |
Why?
|
| Mass Casualty Incidents | 1 | 2020 | 2 | 0.670 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 117 | 0.660 |
Why?
|
| Middle Aged | 33 | 2024 | 12222 | 0.660 |
Why?
|
| Aged | 28 | 2024 | 8214 | 0.660 |
Why?
|
| Poisson Distribution | 1 | 2020 | 44 | 0.650 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 57 | 0.650 |
Why?
|
| Eye Injuries | 1 | 2020 | 6 | 0.650 |
Why?
|
| Education, Professional | 1 | 2020 | 9 | 0.650 |
Why?
|
| Staff Development | 1 | 2020 | 30 | 0.650 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 30 | 0.650 |
Why?
|
| Computer-Assisted Instruction | 1 | 2020 | 26 | 0.640 |
Why?
|
| Faculty, Medical | 1 | 2020 | 74 | 0.630 |
Why?
|
| Adenocarcinoma | 3 | 2015 | 291 | 0.610 |
Why?
|
| Pain Measurement | 1 | 2020 | 183 | 0.600 |
Why?
|
| Resilience, Psychological | 1 | 2020 | 106 | 0.590 |
Why?
|
| Paternal Age | 1 | 2018 | 4 | 0.580 |
Why?
|
| Health Promotion | 2 | 2026 | 704 | 0.580 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.570 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.570 |
Why?
|
| Internet | 1 | 2020 | 236 | 0.570 |
Why?
|
| Anti-Bacterial Agents | 9 | 2011 | 432 | 0.570 |
Why?
|
| Sterilization, Reproductive | 1 | 2018 | 2 | 0.560 |
Why?
|
| Young Adult | 14 | 2020 | 5080 | 0.560 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 27 | 0.560 |
Why?
|
| Mexico | 6 | 2026 | 298 | 0.560 |
Why?
|
| Eye Diseases | 2 | 2012 | 29 | 0.560 |
Why?
|
| Schools, Medical | 1 | 2020 | 208 | 0.550 |
Why?
|
| Child, Preschool | 12 | 2018 | 1546 | 0.540 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 15 | 0.530 |
Why?
|
| Curriculum | 1 | 2020 | 318 | 0.530 |
Why?
|
| Stomach Neoplasms | 2 | 2012 | 241 | 0.520 |
Why?
|
| Infant | 9 | 2022 | 1175 | 0.510 |
Why?
|
| Male | 36 | 2026 | 23409 | 0.510 |
Why?
|
| Child | 14 | 2018 | 3443 | 0.500 |
Why?
|
| Pregnancy Outcome | 2 | 2018 | 102 | 0.500 |
Why?
|
| Ovarian Neoplasms | 2 | 2012 | 415 | 0.500 |
Why?
|
| Age Factors | 9 | 2020 | 1154 | 0.490 |
Why?
|
| Appendicitis | 1 | 2016 | 18 | 0.490 |
Why?
|
| Smoking | 1 | 2023 | 1024 | 0.480 |
Why?
|
| Incidence | 8 | 2020 | 1078 | 0.460 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2015 | 12 | 0.450 |
Why?
|
| Aged, 80 and over | 13 | 2020 | 2853 | 0.440 |
Why?
|
| Case-Control Studies | 7 | 2017 | 1285 | 0.440 |
Why?
|
| Hypotension | 2 | 2005 | 24 | 0.420 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 146 | 0.410 |
Why?
|
| Registries | 3 | 2020 | 437 | 0.400 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2019 | 989 | 0.400 |
Why?
|
| Infant, Newborn | 7 | 2022 | 972 | 0.390 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 8 | 0.380 |
Why?
|
| Clindamycin | 4 | 2007 | 13 | 0.380 |
Why?
|
| Insurance Coverage | 2 | 2020 | 110 | 0.380 |
Why?
|
| Hyponatremia | 1 | 2012 | 6 | 0.380 |
Why?
|
| Obstetrics | 4 | 2019 | 43 | 0.380 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2012 | 3 | 0.380 |
Why?
|
| Insulin Infusion Systems | 1 | 2012 | 8 | 0.380 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 497 | 0.380 |
Why?
|
| Accidental Falls | 1 | 2012 | 33 | 0.370 |
Why?
|
| Hip Fractures | 1 | 2012 | 29 | 0.370 |
Why?
|
| Hypoglycemia | 1 | 2012 | 24 | 0.370 |
Why?
|
| Emergency Service, Hospital | 2 | 2012 | 278 | 0.370 |
Why?
|
| United States | 13 | 2018 | 5205 | 0.370 |
Why?
|
| Carcinosarcoma | 1 | 2012 | 4 | 0.370 |
Why?
|
| Serum Albumin | 2 | 2009 | 59 | 0.360 |
Why?
|
| Hospital Charges | 1 | 2012 | 15 | 0.360 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 247 | 0.360 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2012 | 18 | 0.360 |
Why?
|
| Logistic Models | 7 | 2016 | 1009 | 0.350 |
Why?
|
| Peanut Hypersensitivity | 1 | 2011 | 1 | 0.350 |
Why?
|
| Death Certificates | 1 | 2011 | 15 | 0.340 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2010 | 19 | 0.330 |
Why?
|
| Intensive Care Units | 3 | 2012 | 72 | 0.330 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2010 | 4 | 0.320 |
Why?
|
| Insulin | 1 | 2012 | 258 | 0.320 |
Why?
|
| Postoperative Complications | 1 | 2012 | 263 | 0.320 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 184 | 0.320 |
Why?
|
| Hospitals, State | 1 | 2010 | 1 | 0.320 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2010 | 4 | 0.320 |
Why?
|
| Drug Hypersensitivity | 1 | 2010 | 6 | 0.320 |
Why?
|
| Glucose Tolerance Test | 1 | 2010 | 75 | 0.320 |
Why?
|
| Melanoma | 2 | 2009 | 110 | 0.310 |
Why?
|
| Models, Statistical | 2 | 2011 | 195 | 0.310 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2009 | 3 | 0.300 |
Why?
|
| Placental Insufficiency | 1 | 2009 | 2 | 0.300 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2008 | 34 | 0.300 |
Why?
|
| Gestational Age | 3 | 2023 | 200 | 0.300 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 125 | 0.300 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 62 | 0.300 |
Why?
|
| Parturition | 1 | 2009 | 22 | 0.300 |
Why?
|
| Uveal Neoplasms | 1 | 2009 | 11 | 0.300 |
Why?
|
| Cardiovascular Diseases | 2 | 2015 | 749 | 0.300 |
Why?
|
| Comorbidity | 6 | 2020 | 737 | 0.290 |
Why?
|
| Helicobacter Infections | 4 | 2011 | 86 | 0.280 |
Why?
|
| Primary Health Care | 1 | 2012 | 380 | 0.280 |
Why?
|
| Gynecology | 4 | 2019 | 35 | 0.280 |
Why?
|
| Insect Bites and Stings | 1 | 2007 | 3 | 0.280 |
Why?
|
| Postpartum Period | 1 | 2008 | 92 | 0.280 |
Why?
|
| Helicobacter pylori | 4 | 2011 | 118 | 0.280 |
Why?
|
| Purpura | 1 | 2007 | 3 | 0.270 |
Why?
|
| Kidney Diseases | 1 | 2010 | 172 | 0.270 |
Why?
|
| International Classification of Diseases | 3 | 2015 | 27 | 0.270 |
Why?
|
| Ophthalmology | 2 | 2012 | 34 | 0.270 |
Why?
|
| Cellulitis | 1 | 2007 | 6 | 0.270 |
Why?
|
| Endometrial Neoplasms | 2 | 2024 | 79 | 0.270 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2007 | 30 | 0.270 |
Why?
|
| Coccidioidomycosis | 1 | 2007 | 54 | 0.250 |
Why?
|
| Emergency Medicine | 2 | 2010 | 33 | 0.250 |
Why?
|
| Schools | 2 | 2026 | 283 | 0.240 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2005 | 2 | 0.240 |
Why?
|
| Asthma | 1 | 2010 | 416 | 0.240 |
Why?
|
| Accidents, Home | 1 | 2005 | 8 | 0.240 |
Why?
|
| Ultrasonography | 3 | 2019 | 135 | 0.230 |
Why?
|
| Malpractice | 1 | 2005 | 3 | 0.230 |
Why?
|
| Immunogenetics | 1 | 2005 | 2 | 0.230 |
Why?
|
| Walking | 1 | 2026 | 88 | 0.220 |
Why?
|
| Hospitals, Religious | 1 | 2004 | 1 | 0.220 |
Why?
|
| Critical Pathways | 1 | 2004 | 18 | 0.220 |
Why?
|
| Ovariectomy | 2 | 2018 | 127 | 0.220 |
Why?
|
| Nursing Homes | 1 | 2005 | 64 | 0.220 |
Why?
|
| Community-Acquired Infections | 1 | 2004 | 22 | 0.220 |
Why?
|
| Cesarean Section | 2 | 2018 | 63 | 0.210 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 1067 | 0.210 |
Why?
|
| Obesity | 3 | 2010 | 1151 | 0.210 |
Why?
|
| Cohort Studies | 3 | 2018 | 1759 | 0.210 |
Why?
|
| Diabetes Complications | 4 | 2009 | 102 | 0.210 |
Why?
|
| Cross-Sectional Studies | 6 | 2012 | 3156 | 0.210 |
Why?
|
| Salmonella Infections | 1 | 2004 | 16 | 0.210 |
Why?
|
| Pneumonia | 1 | 2004 | 61 | 0.210 |
Why?
|
| Bromhexine | 1 | 2023 | 4 | 0.210 |
Why?
|
| Vaginal Smears | 2 | 2021 | 63 | 0.200 |
Why?
|
| Disease Outbreaks | 1 | 2005 | 175 | 0.200 |
Why?
|
| Internship and Residency | 2 | 2019 | 146 | 0.200 |
Why?
|
| Peritonitis | 1 | 2003 | 11 | 0.200 |
Why?
|
| Neoplasm Staging | 1 | 2024 | 374 | 0.200 |
Why?
|
| Birth Weight | 1 | 2023 | 95 | 0.190 |
Why?
|
| Liver | 2 | 2016 | 511 | 0.190 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2022 | 41 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2018 | 863 | 0.180 |
Why?
|
| Hematologic Diseases | 1 | 2020 | 13 | 0.170 |
Why?
|
| Curettage | 1 | 2020 | 3 | 0.170 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 76 | 0.160 |
Why?
|
| Writing | 1 | 2020 | 42 | 0.160 |
Why?
|
| Microscopy | 1 | 2020 | 35 | 0.160 |
Why?
|
| Confidence Intervals | 2 | 2010 | 162 | 0.160 |
Why?
|
| Medically Underserved Area | 1 | 2020 | 120 | 0.160 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2020 | 43 | 0.160 |
Why?
|
| Leadership | 1 | 2020 | 86 | 0.150 |
Why?
|
| Survival Rate | 4 | 2015 | 355 | 0.150 |
Why?
|
| Medicaid | 2 | 2012 | 143 | 0.150 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 40 | 0.150 |
Why?
|
| Comprehension | 1 | 2019 | 41 | 0.140 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 59 | 0.140 |
Why?
|
| Torsion Abnormality | 1 | 2018 | 3 | 0.140 |
Why?
|
| Ovarian Diseases | 1 | 2018 | 4 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 719 | 0.140 |
Why?
|
| Women's Health Services | 1 | 2018 | 12 | 0.140 |
Why?
|
| Hospitals, Teaching | 1 | 2018 | 33 | 0.140 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 48 | 0.140 |
Why?
|
| Ovulation Induction | 1 | 2017 | 5 | 0.140 |
Why?
|
| Fertility Agents, Female | 1 | 2017 | 8 | 0.140 |
Why?
|
| Clinical Competence | 1 | 2019 | 156 | 0.140 |
Why?
|
| Gonadotropins | 1 | 2017 | 27 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2007 | 20 | 0.130 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2017 | 43 | 0.130 |
Why?
|
| Bayes Theorem | 2 | 2022 | 126 | 0.130 |
Why?
|
| Nitriles | 1 | 2017 | 81 | 0.130 |
Why?
|
| Ovarian Follicle | 1 | 2017 | 44 | 0.130 |
Why?
|
| Language | 1 | 2019 | 185 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 235 | 0.130 |
Why?
|
| Premature Birth | 1 | 2018 | 95 | 0.130 |
Why?
|
| Triazoles | 1 | 2017 | 102 | 0.130 |
Why?
|
| Iron Overload | 1 | 2016 | 10 | 0.120 |
Why?
|
| Cholangitis | 1 | 2016 | 1 | 0.120 |
Why?
|
| CD4-CD8 Ratio | 1 | 2016 | 29 | 0.120 |
Why?
|
| Gene Products, env | 1 | 2016 | 23 | 0.120 |
Why?
|
| Jaundice | 1 | 2016 | 7 | 0.120 |
Why?
|
| Pancreatitis | 1 | 2016 | 21 | 0.120 |
Why?
|
| Abdominal Pain | 1 | 2016 | 24 | 0.120 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 706 | 0.120 |
Why?
|
| Ligaments | 1 | 2015 | 2 | 0.120 |
Why?
|
| Endoscopy | 1 | 2015 | 17 | 0.120 |
Why?
|
| Databases, Factual | 2 | 2010 | 341 | 0.120 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2015 | 5 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2023 | 1604 | 0.120 |
Why?
|
| Hysterectomy | 1 | 2015 | 38 | 0.120 |
Why?
|
| Ureteral Obstruction | 1 | 2015 | 16 | 0.120 |
Why?
|
| Cacao | 1 | 2015 | 10 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2015 | 59 | 0.110 |
Why?
|
| Diabetes, Gestational | 2 | 2019 | 56 | 0.110 |
Why?
|
| Renal Dialysis | 1 | 2016 | 131 | 0.110 |
Why?
|
| Health Personnel | 1 | 2017 | 277 | 0.110 |
Why?
|
| Adenoma | 1 | 2015 | 96 | 0.110 |
Why?
|
| Iron, Dietary | 2 | 2011 | 13 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 236 | 0.110 |
Why?
|
| Cocaine-Related Disorders | 1 | 2015 | 102 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 186 | 0.100 |
Why?
|
| Iron | 1 | 2016 | 251 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 279 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 242 | 0.100 |
Why?
|
| Heart Failure | 2 | 2007 | 302 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 1723 | 0.100 |
Why?
|
| Prognosis | 2 | 2024 | 861 | 0.100 |
Why?
|
| Breech Presentation | 1 | 2012 | 4 | 0.100 |
Why?
|
| Twins | 1 | 2012 | 19 | 0.100 |
Why?
|
| Ferritins | 2 | 2011 | 63 | 0.100 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2012 | 20 | 0.100 |
Why?
|
| Time Factors | 1 | 2017 | 1857 | 0.100 |
Why?
|
| Infant, Low Birth Weight | 1 | 2012 | 36 | 0.100 |
Why?
|
| Nursing Care | 1 | 2012 | 7 | 0.090 |
Why?
|
| Infant Mortality | 1 | 2012 | 65 | 0.090 |
Why?
|
| Fetal Growth Retardation | 1 | 2012 | 53 | 0.090 |
Why?
|
| Sodium | 1 | 2012 | 102 | 0.090 |
Why?
|
| Physicians, Family | 1 | 2012 | 29 | 0.090 |
Why?
|
| Yolk Sac | 1 | 2012 | 4 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2012 | 134 | 0.090 |
Why?
|
| Genital Neoplasms, Female | 1 | 2012 | 17 | 0.090 |
Why?
|
| Risk | 1 | 2012 | 287 | 0.090 |
Why?
|
| Pediatrics | 1 | 2012 | 70 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2012 | 61 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 61 | 0.090 |
Why?
|
| Respiration, Artificial | 1 | 2011 | 44 | 0.090 |
Why?
|
| Health Services Research | 1 | 2012 | 161 | 0.080 |
Why?
|
| New York | 1 | 2011 | 93 | 0.080 |
Why?
|
| Geography | 1 | 2011 | 110 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2012 | 258 | 0.080 |
Why?
|
| Breast Feeding | 1 | 2012 | 126 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 237 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2012 | 456 | 0.080 |
Why?
|
| Anemia, Iron-Deficiency | 2 | 2011 | 20 | 0.080 |
Why?
|
| Cephalosporins | 1 | 2010 | 3 | 0.080 |
Why?
|
| Penicillins | 1 | 2010 | 10 | 0.080 |
Why?
|
| Burnout, Professional | 1 | 2010 | 31 | 0.080 |
Why?
|
| Glucose Intolerance | 1 | 2010 | 40 | 0.080 |
Why?
|
| Fasting | 1 | 2010 | 56 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 231 | 0.080 |
Why?
|
| Markov Chains | 1 | 2009 | 43 | 0.080 |
Why?
|
| Multilingualism | 1 | 2010 | 52 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2009 | 64 | 0.080 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 518 | 0.080 |
Why?
|
| Minnesota | 1 | 2009 | 41 | 0.080 |
Why?
|
| Culture | 1 | 2010 | 172 | 0.070 |
Why?
|
| Medically Uninsured | 1 | 2009 | 65 | 0.070 |
Why?
|
| Paternity | 1 | 2008 | 1 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2015 | 719 | 0.070 |
Why?
|
| Birth Intervals | 1 | 2008 | 3 | 0.070 |
Why?
|
| Medicare | 1 | 2012 | 332 | 0.070 |
Why?
|
| Endometrial Hyperplasia | 1 | 2008 | 3 | 0.070 |
Why?
|
| Drug Therapy, Combination | 3 | 2017 | 234 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 113 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2009 | 224 | 0.070 |
Why?
|
| Age Distribution | 1 | 2009 | 249 | 0.070 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2006 | 17 | 0.070 |
Why?
|
| Recurrence | 1 | 2008 | 152 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 317 | 0.070 |
Why?
|
| Natriuretic Agents | 1 | 2007 | 4 | 0.070 |
Why?
|
| Sentinel Surveillance | 1 | 2008 | 25 | 0.070 |
Why?
|
| Endometrium | 1 | 2008 | 59 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2010 | 389 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 440 | 0.070 |
Why?
|
| HIV Infections | 2 | 2016 | 2586 | 0.070 |
Why?
|
| Reproductive Medicine | 1 | 2007 | 6 | 0.070 |
Why?
|
| Population | 1 | 2007 | 8 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 36 | 0.070 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2007 | 22 | 0.060 |
Why?
|
| Canada | 1 | 2007 | 163 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2007 | 368 | 0.060 |
Why?
|
| Heating | 1 | 2005 | 6 | 0.060 |
Why?
|
| Consumer Product Safety | 1 | 2005 | 10 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 21 | 0.060 |
Why?
|
| Cold Temperature | 1 | 2005 | 40 | 0.060 |
Why?
|
| Space-Time Clustering | 1 | 2005 | 3 | 0.060 |
Why?
|
| Multi-Institutional Systems | 1 | 2004 | 1 | 0.060 |
Why?
|
| Workplace | 1 | 2026 | 92 | 0.060 |
Why?
|
| Protein C | 1 | 2004 | 2 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2004 | 107 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 55 | 0.050 |
Why?
|
| Orbital Diseases | 1 | 2004 | 1 | 0.050 |
Why?
|
| Health Services Administration | 1 | 2004 | 4 | 0.050 |
Why?
|
| Government Agencies | 1 | 2004 | 8 | 0.050 |
Why?
|
| Eyelid Diseases | 1 | 2004 | 5 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2026 | 375 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2004 | 98 | 0.050 |
Why?
|
| Patient Transfer | 1 | 2004 | 25 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2004 | 27 | 0.050 |
Why?
|
| Ofloxacin | 1 | 2003 | 7 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 1081 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 154 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 75 | 0.050 |
Why?
|
| Conjunctival Neoplasms | 1 | 2002 | 1 | 0.050 |
Why?
|
| Observer Variation | 1 | 2002 | 59 | 0.050 |
Why?
|
| ROC Curve | 1 | 2002 | 159 | 0.050 |
Why?
|
| California | 1 | 2004 | 548 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2002 | 132 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2007 | 502 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2002 | 142 | 0.040 |
Why?
|
| Intention to Treat Analysis | 2 | 2011 | 14 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1234 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 384 | 0.040 |
Why?
|
| Myeloproliferative Disorders | 1 | 2020 | 2 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2020 | 8 | 0.040 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 20 | 0.040 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2020 | 19 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 667 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 41 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 38 | 0.040 |
Why?
|
| Mass Screening | 1 | 2005 | 541 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2011 | 317 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2022 | 408 | 0.040 |
Why?
|
| Exercise | 1 | 2026 | 692 | 0.040 |
Why?
|
| Reference Values | 2 | 2011 | 211 | 0.040 |
Why?
|
| Dietary Supplements | 2 | 2011 | 213 | 0.040 |
Why?
|
| Glycemic Index | 1 | 2019 | 10 | 0.040 |
Why?
|
| Pamphlets | 1 | 2019 | 27 | 0.040 |
Why?
|
| Pregnancy, Multiple | 1 | 2018 | 6 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 61 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2018 | 19 | 0.040 |
Why?
|
| Stillbirth | 1 | 2018 | 20 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 359 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 611 | 0.040 |
Why?
|
| Pregnancy Rate | 1 | 2017 | 15 | 0.030 |
Why?
|
| Ovulation | 1 | 2017 | 21 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2017 | 24 | 0.030 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2017 | 27 | 0.030 |
Why?
|
| Rural Population | 1 | 2020 | 373 | 0.030 |
Why?
|
| Poverty | 1 | 2020 | 400 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1028 | 0.030 |
Why?
|
| Health Literacy | 1 | 2019 | 130 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 9 | 0.030 |
Why?
|
| Endometriosis | 1 | 2017 | 83 | 0.030 |
Why?
|
| Cystoscopy | 1 | 2015 | 4 | 0.030 |
Why?
|
| Stents | 1 | 2016 | 67 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 449 | 0.030 |
Why?
|
| SEER Program | 1 | 2015 | 164 | 0.030 |
Why?
|
| Myocardium | 1 | 2016 | 263 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 780 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 587 | 0.020 |
Why?
|
| Abortion, Missed | 1 | 2012 | 1 | 0.020 |
Why?
|
| Monosomy | 1 | 2012 | 2 | 0.020 |
Why?
|
| Turner Syndrome | 1 | 2012 | 2 | 0.020 |
Why?
|
| Trisomy | 1 | 2012 | 11 | 0.020 |
Why?
|
| Karyotyping | 1 | 2012 | 45 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 40 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2016 | 1600 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 39 | 0.020 |
Why?
|
| Health Surveys | 1 | 2012 | 405 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2010 | 32 | 0.020 |
Why?
|
| General Surgery | 1 | 2010 | 28 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 286 | 0.020 |
Why?
|
| Psychiatry | 1 | 2010 | 36 | 0.020 |
Why?
|
| Cities | 1 | 2010 | 79 | 0.020 |
Why?
|
| HIV-1 | 1 | 2016 | 755 | 0.020 |
Why?
|
| Skin Ulcer | 1 | 2009 | 6 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 13 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 760 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1568 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 141 | 0.020 |
Why?
|
| Drug Costs | 1 | 2007 | 35 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2006 | 39 | 0.010 |
Why?
|
| Virulence Factors | 1 | 2006 | 125 | 0.010 |
Why?
|
| Nutrition Surveys | 1 | 2005 | 263 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 712 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 835 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 16992 | 0.000 |
Why?
|